October 12, 2011, New York, NY - 56 million U.S. consumers have accessed their medical information on an electronic health record (EHR) system maintained by their physician, and an additional 41 million are interested in doing so. These findings come from pharmaceutical and healthcare market research company Manhattan Research's new Cybercitizen Health® U.S. 2011 study of consumer digital health trends, which surveyed 8,745 U.S. adults (age 18 and over) online and on the phone in Q3 2011. Additionally, the company's Taking the Pulse® U.S. physician study found that EHR adoption is rising among doctors, and will likely accelerate as iPads and other tablets facilitate EHR access for doctors on the move throughout the workday.

However, despite strong growth in EHR adoption and awareness, 140 million consumers report that they have not used and are not interested in accessing medical records from an EHR system maintained by their physician. Compared to consumers who do access their medical data on an EHR, the audience not interested in doing so is older, less educated, and significantly less likely to use the Internet or own sophisticated electronic devices such as smartphones and tablets.

"Growth in access of electronic health records by patients has been remarkable in the last year," said Meredith Ressi, Manhattan Research President. "There's been strong pent up demand from consumers over the years, but only now has the supply side caught up as a result of the government mandate. This is the beginning of a real shift in care delivery and patient engagement."

Sign up for the Cybercitizen Health® U.S. 2011 Webinar - Thursday, October 20 at 2pm ET

On Thursday October 20 at 2pm ET, Manhattan Research Vice President of Research Monique Levy will host a complimentary webinar about the Cybercitizen Health® U.S. 2011 market research and strategic advisory service. The webinar will also preview some of the key findings from the new study.

To register and learn more, please visit https://decisionresources.webex.com/decisionresources/onstage/g.php?d=761336444&t=a

About Cybercitizen Health® U.S. 2011

Cybercitizen Health® U.S. 2011 was fielded in Q3 2011 among 8,745 U.S. adults (age 18 and over) online and on the phone. More than 80 therapeutic categories are tracked in research, including patient and caregiver populations.

Additional topics covered in the research include:

  • How is the health web evolving and how can marketers leverage emerging online health audiences?
  • How does search and website behavior differ across the disease and treatment pathway?
  • What role is digital health playing at the point of care for doctors?
  • Do consumers want additional support and services from pharmacists and nurses?
  • Is social media adoption for health maturing?
  • To what degree are mobile devices transforming health seeking behavior?
  • How advanced are consumers in terms of recording and sharing their health measurements?
  • Which pain points related to digital on-going care represent the strongest opportunity for health stakeholders?

For more information, please email [email protected], call 1.888.680.0800, ext 2 or visit www.manhattanresearch.com/cch.


About Manhattan Research
Manhattan Research, a Decision Resources Group company, conducts annual research studies covering eHealth trends among healthcare professionals and consumers in the Americas, Europe, and Asia. Broad research can be segmented by target specialist and therapeutic audiences. For more information please contact [email protected], call 1.888.680.0800, ext 2, or visit www.manhattanresearch.com.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.


All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders. 
For more information, contact:
Maureen Malloy
Manhattan Research
[email protected]